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As Ammatuna and Nijziel note (1), obtaining an accurate and comprehensive drug history 
is crucial in the treatment of patients presenting with symptoms that can potentially be 
attributed to the use of anabolic steroids, including renal disorders.!
Most people who use anabolic steroids obtain these drugs from the illicit market (2). Here, 
many products are manufactured in ‘underground laboratories’ operating outside the 
formal parameters of the production of licensed medicinal products (3). In the United 
Kingdom, investigations by the Medicines and Healthcare products Regulatory Agency 
(MHRA) have highlighted the issue of adulterated drugs on the UK illicit market, including 
anabolic agents, leading to drug seizures, arrests and illicit online retailers being shut 
down (4). In a number of cases, drug testing and analysis has identified that drugs 
claiming to contain anabolic steroids contain a different amount of pharmacologically 
active substance than declared on the label, a different active substance or no active 
substance whatsoever (3). Due to poor manufacturing, products might also be accidentally 
contaminated with toxic chemicals and injectable products might be unsterile, resulting in 
local or systemic infections (2). In addition, many people who use anabolic steroids take a 
variety of off-the-shelf products marketed as dietary or nutritional supplements that are 
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increasingly being found to contain pharmacologically active substances, such as appetite 
suppressants, sildenafil (used for erectile dysfunction) and stimulants, that have not been 
listed on the package (2). The fact that in most cases, anabolic steroid users remain 
unaware of their intake of specific active substances, means that many case reports 
regarding patients’ use of these drugs suffer from an over-reliance on self-reported drug 
use (5).!
Healthcare professionals who come into contact with patients using anabolic steroids 
should be aware of these issues. Where possible, and when resources are available, drug 
vials, tablets and/or biological samples should be collected and submitted to drug analysis 
to identify the pharmacologically active substance, along with any contamination. These 
data will add considerably to information retrieved from the patients’ drug histories (1), 
improving both diagnosis and prognosis. Furthermore, collecting data on the contents of 
these products will contribute to our understanding of the causal relationship between 
anabolic steroids and specific health harms in case reports pertaining to patients’ usage of 
these drugs (6).!
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